Shahzad Malik Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shahzad Malik.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shahzad Malik. Shahzad Malik is Director in AGENUS INC ($AGEN) and Director in Conatus Pharmaceuticals Inc. ($CNAT) and Director in Versartis, Inc. ($VSAR) and Director in Acutus Medical, Inc. ($AFIB) and Director in Axonics Modulation Technologies, Inc. ($AXNX) and Director in Iterum Therapeutics plc ($ITRM).
Latest Insider Trading Transactions of Shahzad Malik
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AFIB, AGEN, ARAV, AXNX, HSTO, ITRM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 12 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 171,695 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 7,242 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 312,840 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 13,195 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 812,683 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 34,261 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 254,495 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 10,738 | 0 | 0 | |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Buy | C | 0.00 | 1,551,713 | 0 | 1,551,713 | 0 to 1.6 M |
Aug 12 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Buy | C | 0.00 | 65,436 | 0 | 65,436 | 0 to 65.4 K |
Aug 07 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Option Exercise | A | 18.00 | 12,454 | 224,172 | 12,454 | |
Aug 07 2020 | AFIB | Acutus Medical, In ... | Malik Shahzad | Director | Grant | A | 0.00 | 2,222 | 0 | 2,222 | 0 to 2.2 K |
Sep 13 2019 | ARAV | Aravive, Inc. | Malik Shahzad | Director | Option Exercise | A | 5.77 | 7,500 | 43,275 | 7,500 | |
Jun 17 2019 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | A | 6.74 | 19,671 | 132,583 | 19,671 | |
Jan 07 2019 | VSAR | Aravive, Inc. | Malik Shahzad | Director | Option Exercise | A | 3.69 | 4,688 | 17,299 | 4,688 | |
Dec 10 2018 | AXNX | Axonics Modulation ... | Malik Shahzad | Director | Option Exercise | A | 14.80 | 5,000 | 74,000 | 5,000 | |
Dec 10 2018 | AXNX | Axonics Modulation ... | Malik Shahzad | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Nov 02 2018 | AXNX | Axonics Modulation ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 337,447 | 0 | 0 | |
Nov 02 2018 | AXNX | Axonics Modulation ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 12,010 | 0 | 0 | |
Nov 02 2018 | AXNX | Axonics Modulation ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 1,025,981 | 0 | 0 | |
Nov 02 2018 | AXNX | Axonics Modulation ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 36,518 | 0 | 0 | |
Nov 02 2018 | AXNX | Axonics Modulation ... | Malik Shahzad | Director | Buy | C | 0.00 | 404,937 | 0 | 1,694,349 | 1.3 M to 1.7 M (+31.40 %) |
Nov 02 2018 | AXNX | Axonics Modulation ... | Malik Shahzad | Director | Buy | C | 0.00 | 14,412 | 0 | 1,289,412 | 1.3 M to 1.3 M (+1.13 %) |
Nov 02 2018 | AXNX | Axonics Modulation ... | Malik Shahzad | Director | Buy | C | 0.00 | 1,231,178 | 0 | 1,275,000 | 43.8 K to 1.3 M (+2,809.50 %) |
Nov 02 2018 | AXNX | Axonics Modulation ... | Malik Shahzad | Director | Buy | C | 0.00 | 43,822 | 0 | 43,822 | 0 to 43.8 K |
May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 218,338 | 0 | 0 | |
May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 391,147 | 0 | 0 | |
May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 7,771 | 0 | 0 | |
May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 13,921 | 0 | 0 | |
May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | P | 13.00 | 228,840 | 2,974,920 | 838,325 | 609.5 K to 838.3 K (+37.55 %) |
May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | C | 0.00 | 218,338 | 0 | 609,485 | 391.1 K to 609.5 K (+55.82 %) |
May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | C | 0.00 | 391,147 | 0 | 391,147 | 0 to 391.1 K |
May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | P | 13.00 | 8,144 | 105,872 | 29,836 | 21.7 K to 29.8 K (+37.54 %) |
May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | C | 0.00 | 7,771 | 0 | 21,692 | 13.9 K to 21.7 K (+55.82 %) |
May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | C | 0.00 | 13,921 | 0 | 13,921 | 0 to 13.9 K |
May 29 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | A | 13.00 | 11,241 | 146,133 | 11,241 | |
Dec 22 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Grant | A | 0.00 | 11,200 | 0 | 23,880 | 12.7 K to 23.9 K (+88.33 %) |
Jun 06 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Option Exercise | A | 15.83 | 6,850 | 108,401 | 6,850 | |
Jun 06 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Grant | A | 0.00 | 3,480 | 0 | 12,680 | 9.2 K to 12.7 K (+37.83 %) |
Mar 17 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 18.01 | 386,367 | 6,958,470 | 1,621,558 | 2 M to 1.6 M (-19.24 %) |
Mar 17 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 18.50 | 97,303 | 1,800,106 | 2,007,925 | 2.1 M to 2 M (-4.62 %) |
Mar 15 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 19.08 | 103,122 | 1,967,568 | 2,105,228 | 2.2 M to 2.1 M (-4.67 %) |
Mar 15 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 19.00 | 46,778 | 888,782 | 2,208,350 | 2.3 M to 2.2 M (-2.07 %) |
Mar 15 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 19.03 | 100 | 1,903 | 2,255,128 | 2.3 M to 2.3 M (0.00 %) |
Mar 15 2017 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Sell | S | 19.42 | 16,330 | 317,129 | 2,255,228 | 2.3 M to 2.3 M (-0.72 %) |
Jun 27 2016 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Option Exercise | A | 2.13 | 20,000 | 42,600 | 20,000 | |
Jun 17 2016 | AGEN | AGENUS INC | Malik Shahzad | Director | Option Exercise | A | 3.91 | 35,000 | 136,850 | 35,000 | |
May 20 2016 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Option Exercise | A | 8.12 | 14,625 | 118,755 | 14,625 | |
May 20 2016 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Grant | A | 0.00 | 4,625 | 0 | 9,200 | 4.6 K to 9.2 K (+101.09 %) |
Jul 01 2015 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Option Exercise | A | 14.73 | 13,100 | 192,963 | 13,100 | |
Jul 01 2015 | VSAR | Versartis, Inc. | Malik Shahzad | Director | Grant | A | 0.00 | 4,575 | 0 | 4,575 | 0 to 4.6 K |
Jun 29 2015 | AGEN | AGENUS INC | Malik Shahzad | Director | Option Exercise | A | 8.43 | 18,750 | 158,063 | 18,750 | |
Jun 15 2015 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Option Exercise | A | 5.52 | 15,000 | 82,800 | 15,000 | |
May 27 2015 | AGEN | AGENUS INC | Malik Shahzad | Director | Buy | J | 6.30 | 1,587,302 | 10,000,003 | 1,587,302 | 0 to 1.6 M |
Apr 30 2015 | AGEN | AGENUS INC | Malik Shahzad | Director | Sell | S | 7.02 | 407,377 | 2,858,809 | 0 | 407.4 K to 0 (-100.00 %) |
Apr 30 2015 | AGEN | AGENUS INC | Malik Shahzad | Director | Sell | S | 7.16 | 700,000 | 5,012,560 | 407,377 | 1.1 M to 407.4 K (-63.21 %) |
Apr 30 2015 | AGEN | AGENUS INC | Malik Shahzad | Director | Buy | J | 3.00 | 111,289 | 333,756 | 1,107,377 | 996.1 K to 1.1 M (+11.17 %) |
Page: 1